PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Appoints Business Development Consultant, page-256

  1. 954 Posts.
    lightbulb Created with Sketch. 286
    PAR might just prove to be the best gaslighters I’ve come across.

    So much crap spouted about addressing OA and pushing out timelines infinitely while really a plain old repurposed drug was bandied about to subsidise a lifestyle co.

    Shameful.

    I don’t think an EGM is far away. PR needs to go completely.

    To the old ex director muppet who stood up at the AGM, brought it to a standstill, and performed a gross act of public fellatio on PR, you are deserving of a Beaza punch in the head.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.